Breast Neoplasms: all 12,820 studies
Page 19 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast CancerRecruitingNCT06246968Phase 1
- PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBCRecruitingNCT06245889Phase 2
- Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer TrialNot yet recruitingNCT06245824Phase 4
- Estrogen Receptors and HER2 Levels' Expression in Luminal Metastatic Breast CancerRecruitingNCT06243432
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world StudyRecruitingNCT06240195
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsRecruitingNCT06239194Phase 1/2
- Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain MetastasesRecruitingNCT06238921Phase 1/2
- The Effect of Training Given by Whatsapp Application on Mamography Health Beliefs and BehaviorsNot yet recruitingNCT06238453
- HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab GovitecanRecruitingNCT06236269Phase 2
- A Clinical Study of Darcilil Combined With AI Combined With Pyrrotinib in the Treatment of TPBCRecruitingNCT06235931Not applicable
- Aerobic Dance During Chemotherapy in Breast Cancer Patients With Cognitive ImpairmentNot yet recruitingNCT06234150Not applicable
- A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast CancerRecruitingNCT06234137Not applicable
- CtDNA Based MRD Testing for NAC Monitoring in TNBCRecruitingNCT06230185
- Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast CancerNot yet recruitingNCT06229067Phase 2
- Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.RecruitingNCT06227728
- ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing StudyRecruitingNCT06227338Not applicable
- Neoadjuvant Study of DV in Combination Toripalimab or Sequence Chemotherapy in HR-negative, HER2 Low-expressing Breast CancerRecruitingNCT06227117Phase 2
- Neoadjuvant Chemotherapy With or Without GnRH Agonist for Premenopausal Triple-negative Early Breast Cancer PatientsRecruitingNCT06225284Phase 2
- Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast CancerNot yet recruitingNCT06223698Phase 3
- The Effects of HER2 Receptor Signaling on Human Brown Fat ActivityRecruitingNCT06222957
- Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06222879Phase 1/2
- Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT)RecruitingNCT06222788Not applicable
- The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world StudyRecruitingNCT06220630
- Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast CancerRecruitingNCT06220214Early Phase 1
- Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast CancerRecruitingNCT06217874
- The Added Value of Contrast Enhanced Mammography to Standard Mammography in Assessing the Extent of DCISNot yet recruitingNCT06217458Not applicable
- The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).RecruitingNCT06217185Phase 4
- The Effects of Dance for Breast Cancer Patients Undergoing Surgical TreatmentRecruitingNCT06215027Not applicable
- Anti-Inflammatory Diet in BRC Patients on Aromatase InhibitorsRecruitingNCT06214598Not applicable
- Mind Programme for Women With Breast Cancer (Nationwide Coverage)RecruitingNCT06212414Not applicable
- A Study to Assess the Effectiveness of Trastuzumab Deruxtecan in Chinese Breast Cancer Patients (REFRESH)RecruitingNCT06210776
- Clinical Study of High-intensity Focused Ultrasound Tumor Treatment System(Super Knife) in the Treatment of Breast CancerRecruitingNCT06210529Not applicable
- Patterns of Relapse After Neoadjuvant Chemotherapy in Breast CancerNot yet recruitingNCT06210347
- Discontinuation of CDK4/6 Inhibitors in Patients With Metastatic HR Positive, HER2 Negative Breast CancerRecruitingNCT06207734Phase 2
- Study of Cadonilimab (AK104) Plus Eribulin vs. Eribulin Monotherapy for Recurrent or Metastatic Triple-negative Breast CancerNot yet recruitingNCT06202313Phase 2
- A Study of TQB2930 for Injection Monotherapy or Combination Therapy in Patients With Recurrent/Metastatic Breast CancerRecruitingNCT06202261Phase 1/2
- A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.RecruitingNCT06202118Not applicable
- Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast CancerRecruitingNCT06201234Phase 2
- Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast CancerRecruitingNCT06199895Phase 2
- Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast CancerRecruitingNCT06197581Not applicable
- Autologous vs. Implant-based Breast ReconstructionRecruitingNCT06195865Not applicable
- ECLECTIC: EstroTEP and Circulating Biomarkers for ER-positive HER2-negative Metastatic Breast Cancer PatientsRecruitingNCT06195709Phase 3
- Impact of CASP3 Gene in ChemoresistanceNot yet recruitingNCT06195371
- Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk ReductionRecruitingNCT06195306Phase 2
- Serum Estradiol (E2) Levels in Breast Cancer Patients During Endocrine Therapy by High Performance Liquid Chromatography-tandem Mass Spectrometry (LC-MS /MS)RecruitingNCT06195202
- 99mTc-ABH2 SPECT/CT in Breast CancerRecruitingNCT06194565Not applicable
- Intelligent Remote Intervention for High-risk Breast Cancer PopulationsNot yet recruitingNCT06193707Not applicable
- FUnctional Selection of Advanced Breast Cancer Patients for Talazoparib Treatment Using the REpair Capacity (RECAP) TestRecruitingNCT06193525Phase 2
- Digital Peer Navigation for Adolescents and Young Adults With CancerRecruitingNCT06193369Not applicable
- Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant TreatmentNot yet recruitingNCT06193122
- Novel Magnetic Resonance Imaging-Guided Ultrasound-Stimulated Microbubble Radiation Treatment for Patients With Chest-Wall and Breast CancerRecruitingNCT06185972Phase 2
- Evaluation of Different Imaging Modalities in Regional Lymph Nodes Staging in Patients With Breast CancerRecruitingNCT06185946
- A Simplified Approach to Predicting the Malignancy of Breast Lesions: Nomogram in UltrasonographyNot yet recruitingNCT06185855
- FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided TherapyRecruitingNCT06185569
- ASHBY: Accelerated Super-Hypofractionated Breast BrachytherapyRecruitingNCT06185205Phase 2
- Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE TrialRecruitingNCT06184750Phase 2
- Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)RecruitingNCT06182306
- Effect of BOSU Exercises Added to Complete Decongestive Treatment on Balance in Breast Cancer-associated Lymphedema.Not yet recruitingNCT06182046Not applicable
- Reliability and Validity of Ultrasound for the Assessment of Soft Tissue Properties After Breast Cancer TreatmentRecruitingNCT06180642
- DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast CancerRecruitingNCT06178159Phase 2
- Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical TrialRecruitingNCT06176534Phase 2
- DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEsRecruitingNCT06176261Phase 2
- Evaluation of Pregnancy Associated Plasma Protein A (PAPPA) as a Biomarker in Breast Cancer.Not yet recruitingNCT06174571
- Analgesic Efficacy of Maxigesic in Breast Cancer SurgeryRecruitingNCT06174363Not applicable
- Influence of Intermittent Fasting on Locally Advanced Breast Cancer PatientsRecruitingNCT06174259Not applicable
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06172478Phase 2
- A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast CancerRecruitingNCT06172322Phase 1
- Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast MassesRecruitingNCT06171607Phase 1
- A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 InhibitorsRecruitingNCT06171360
- Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)RecruitingNCT06169371Phase 4
- Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer PatientsRecruitingNCT06169072Phase 2
- Using of Costimulatory and co Inhibatory Immune Checkpoints as Diagnostic and Prognostic in Breast CancerNot yet recruitingNCT06169007
- Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast CancerRecruitingNCT06167694Phase 1/2
- The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled StudyRecruitingNCT06166953Not applicable
- Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBCRecruitingNCT06165900Phase 2
- Effects of Diet and Osteopathy on Quality of Life and Inflammation in Breast Cancer Patients Under Hormonal TherapyRecruitingNCT06164119Not applicable
- Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 StudyRecruitingNCT06162559Phase 1
- Effect of Ultrasound Combined With Microbubbles on Blood Perfusion in Invasive Breast CancerRecruitingNCT06158217
- Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast CancerRecruitingNCT06155305
- Anastrozole Adjuvant Trial - Study of Anastrozole Compared to NOLVADEX (Tamoxifen Citrate) for Adjuvant Treatment of Early Breast Cancer Clinical Studies), Adjunct Cytotoxic Chemotherapy and Malignant Joint TumorNot yet recruitingNCT06154590
- Pyrotinib Combined With Capecitabine and Bevacizumab for Patients With HER2 Positive Breast Cancer and Brain MetastasesRecruitingNCT06152822Phase 2
- Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National ProjectRecruitingNCT06152419Not applicable
- Evaluate the Meritup Oral Solution to Decrease Fatigue in Metastatic Breast Cancer Patients Receiving ChemotherapyNot yet recruitingNCT06151249Phase 2
- Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)RecruitingNCT06150898Phase 2
- Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HR+/HER2 - Advanced Breast CancerRecruitingNCT06149130Phase 2
- CBD for Breast Cancer Primary TumorsRecruitingNCT06148038Phase 1
- Motiva Flora® Aesthetic Breast Recon® Clinical StudyRecruitingNCT06146231Not applicable
- Metastases Directed Therapy for Oligometastatic Breast CancerRecruitingNCT06144346Not applicable
- A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast CancerRecruitingNCT06144164Phase 3
- Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer PatientsRecruitingNCT06142344Not applicable
- The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.Not yet recruitingNCT06140576Phase 1/2
- RADIANT: Pre-op Radiation With Abemaciclib and LetrozoleRecruitingNCT06139107Phase 1
- Metastasis-directed Therapy for Oligometastases of Breast CancerRecruitingNCT06135714Phase 3
- Efficacy of T-Dxd in the Treatment of HER2-positive BCBM After Prior PyrotinibRecruitingNCT06135194
- ALDH1A1 Expression in Invasive Mammary CarcinomaEnrolling by invitationNCT06134570
- Healthy ME: Advancing Health Equity in Lymphatic Pain and Lymphedema in Black and Hispanic Women With Breast CancerNot yet recruitingNCT06133959Not applicable
- Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant ChemotherapyNot yet recruitingNCT06131632Not applicable
- Overcoming Therapy Resistance in ER+ Breast Cancer Patients: a Translational Project (OVERTuRE)RecruitingNCT06129786
- Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral BreastRecruitingNCT06129747Phase 2